A recent Respiratory Medicine digest,
as sent to subscribers

Study Type: Secondary analysis of a randomized trial

Key Question: What bedside factors determine tidal recruitment/derecruitment in spontaneously breathing ARDS patients on pressure support ventilation?

Key Findings:

• EIT-guided PEEP reduced tidal recruitment/derecruitment compared to low PEEP/FiO2 table strategy (11.3% vs 21.9%, P=0.008)
• Independent predictors of higher tidal recruitment/derecruitment were more negative end-expiratory transpulmonary pressure, greater lung collapse, and non-focal infiltrate patterns
• Higher respiratory drive and effort correlated with increased tidal recruitment/derecruitment

Clinical Relevance: This study provides bedside EIT-based approach to identify and minimize harmful tidal recruitment/derecruitment in spontaneously breathing ARDS patients, potentially informing PEEP titration strategies in UK ICUs.

Limitations: Secondary analysis of small study (29 patients) limits generalizability of findings.

Study Type: Multicenter retrospective cohort study

Key Question: What are the clinically meaningful thresholds for 1-year change in quantitative CT-derived fibrosis scores in idiopathic pulmonary fibrosis patients?

Key Findings:

• Minimal clinically important difference thresholds were 2.72% for FVC-anchored and 4.52% for DLco-anchored fibrosis score changes, with an optimal prognostic threshold of 4.05%
• One-year fibrosis score increases ≥4.05% were independently associated with worse transplant-free survival (adjusted HR 2.78, 95%CI 1.36-5.68 in validation cohort)
• These thresholds consistently predicted both overall and 3-year transplant-free survival across discovery (n=524) and validation (n=224) cohorts

Clinical Relevance: This establishes validated quantitative CT thresholds that could standardise IPF monitoring in UK respiratory services, potentially improving risk stratification and treatment decisions during annual follow-up assessments.

Limitations: Retrospective design limits generalisability and the study used specific automated algorithms that may not be universally available across NHS trusts.

Study Type: Consensus statement/research prioritization framework

Key Question: What are the evidence gaps and research priorities for improving the US Air Quality Index as a tool to protect respiratory health?

Key Findings:

• Systematic literature review revealed significant gaps: limited studies on AQI effectiveness in changing behaviour, few assessments of health outcomes from AQI use, and minimal research on how respiratory patients interpret AQI messaging
• Five priority research domains identified: AQI structure, sub-daily exposure estimation, communication strategies, clinical/community implementation, and evaluation of health outcomes
• Specific recommendations include evaluating multi-pollutant AQI structures, assessing patient interpretation of AQI messaging, and measuring whether AQI-informed behaviours reduce exposure and improve health outcomes

Clinical Relevance: UK respiratory clinicians could apply these research priorities to evaluate air quality communication tools used in the UK, particularly given similar challenges in translating air pollution data into actionable patient guidance.

Limitations: This is a research prioritization statement rather than empirical research, so provides framework rather than evidence of interventions.

Study Type: Cross-sectional observational study

Key Question: Are CT-assessed pulmonary vascular abnormalities associated with presence and severity of pulmonary hypertension in COPD and fibrosing interstitial lung disease?

Key Findings:

• Severe PH was associated with reduced small artery volume normalised to total arterial volume (BV5art/TAV ratio) in both COPD and ILD, with more pronounced changes in COPD
• COPD patients showed no correlation between emphysema extent and hemodynamic impairment, whilst ILD patients demonstrated inverse correlation between fibrosis extent and small vessel volumes but no correlation with hemodynamics
• The BV5art/TAV ratio appears to be a sensitive CT marker for hemodynamically confirmed severe PH, particularly in COPD

Clinical Relevance: This provides potential non-invasive CT biomarkers for identifying severe PH in chronic lung diseases, which could inform timing of right heart catheterisation and PH-specific therapy initiation in UK respiratory services.

Limitations: Cross-sectional design prevents assessment of temporal relationships between vascular remodelling and PH progression.

Study Type: Narrative review

Key Question: What is the current evidence for detecting and managing smoking-related comorbidities (beyond lung cancer) identified during low-dose CT lung cancer screening?

Key Findings:

• LDCT screening frequently detects smoking-related conditions including emphysema, coronary artery calcium, interstitial lung abnormalities, osteoporosis, and sarcopenia
• These incidental findings are highly prevalent and independently associated with increased morbidity and mortality
• AI-based automated detection tools are emerging to enable standardised quantification and reporting of these additional findings

Clinical Relevance: This is highly relevant for UK respiratory clinicians as NHS lung health checks expand, potentially informing how to maximise the preventive value of LDCT screening beyond cancer detection.

Limitations: Review does not provide specific prevalence data or quantified mortality associations, and acknowledges ongoing uncertainty about clinical benefit and resource implications.

Study Type: Critical review/commentary

Key Question: Should spirometry prediction equations incorporate ancestry-based differences or use "race-neutral" equations as recommended by ATS/ERS in 2023?

Key Findings:

• Authors argue against the 2023 ATS/ERS recommendation for single "race-neutral" prediction equations derived from weighted averaging across ancestral groups
• Present evidence that spirometric differences between geographic ancestries are primarily inherent/physiological rather than acquired through socioeconomic factors
• Support ancestry-based predictions using anthropological data on thoracic morphology and ecogeographic variation from human evolutionary history

Clinical Relevance: Directly challenges current UK spirometry practice following international guidelines, potentially affecting interpretation of lung function tests across diverse patient populations in NHS respiratory services.

Limitations: As a review/commentary, this represents expert opinion rather than new empirical data on prediction equation accuracy.

Study Type: Prospective cohort study

Key Question: What are the underlying mechanisms of asthma exacerbations that occur in patients with severe eosinophilic asthma despite treatment with benralizumab?

Key Findings:

• Blood eosinophils were suppressed to 0 cells/μL at exacerbation, confirming effective eosinophil depletion
• Airway neutrophilia was present in 55% of exacerbations (27/49 samples), with elevated neutrophil elastase and azurocidin-1 levels
• Viral pathogens were detected in 56% of samples, with new bacterial acquisition (particularly Moraxella catarrhalis, Haemophilus influenzae) occurring in 13-18% of cases

Clinical Relevance: This study provides mechanistic insights for UK respiratory clinicians managing breakthrough exacerbations in severe asthma patients on benralizumab, suggesting infection-driven rather than eosinophilic pathways predominate.

Limitations: Only 49 of 121 exacerbations had adequate sputum samples for comprehensive airway inflammatory analysis.